Test Kit Research & Comparison Center
Test kit research and comparison
What each documented test detects, at what cutoff, in what kind of study, and how strong that evidence is. Every figure links to the page and table it came from.
Costs and our role
The random scheduling and accountability service is free. Test kits and any laboratory testing are purchased separately. Buying a test kit is never required to create or use a free schedule.
P in the Cup does not perform the testing or certify these products. We do not sell tests, we have no affiliate relationships and we currently do not earn affiliate commissions, so there are no paid or affiliate links on these pages.
Before you rely on any home test
Home tests are screening tests. A preliminary positive should be confirmed by an appropriate laboratory test before serious action is taken. A negative result does not rule out substance use. Follow the exact test instructions and consult a healthcare professional about interpretation.
Source: U.S. Food and Drug Administration, "Drugs of Abuse Home Use Test".
Evidence table
Records we have checked against the source
Five records: three FDA 510(k) clearances and two independent studies. Each was opened and read on 21 October 2026; each figure on a record page names its PDF page and table. Nothing here is a ranking, and no record is a product recommendation.
| Compare | Product / study | Intended use | Sample | Analytes | Cutoff example | Evidence tier | Report / source link | Key limitations | Buy link |
|---|---|---|---|---|---|---|---|---|---|
| UCP Home Drug Screening Test Cards and Cup K091588, UCP Biosciences, Inc. |
Over the counter (home use) and health care professional use | Urine | AMP, BAR, BZO, COC, MTD, MET, MDMA, MOP, OPI, OXY, PCP, TCA, THC | AMP 1,000 ng/mL; THC 50 ng/mL; PCP 25 ng/mL (13 cutoffs listed) | B (FDA review of sponsor data) | FDA 510(k) decision summary K091588 | Sponsor-run lay-user study with spiked urine, cleared in 2009; agreement is lower near the cutoff and figures do not transfer to other brands, later lots or white-label products. | No verified retailer link | |
| UCP Rapid Drug Screening BUP, AMP 300, mAMP 500 and Cocaine 150 Tests K091612, UCP Biosciences, Inc. |
Prescription use in point-of-care settings (not a consumer retail kit) | Urine | AMP, BUP, COC, MET | BUP 10, AMP 300, mAMP 500, COC 150 ng/mL | B (FDA review of sponsor data) | FDA 510(k) decision summary K091612 | Prescription point-of-care device, not cleared for home use; sponsor studies with 30 determinations per concentration and 80 clinical samples per drug per format. | No verified retailer link | |
| Healstone Accurate Drug of Abuse Urine Test Cup K221871, Healstone Biotech, Inc. |
Over the counter (home use); a separate Rx version is covered by the same clearance | Urine | AMP, BUP, BAR, BZO, COC, EDDP, MET, MDMA, OPI, MOP, MTD, OXY, PCP, PPX, TCA, THC | AMP 1,000 or 500 ng/mL; THC 50 ng/mL (per the applicant's indications for use) | Unverified for performance (clearance record verified) | FDA decision summary K221871 (Triage-Quick Review) | Clearance verified, but the FDA decision summary is a one-page triage memo with no performance data; figures in the applicant's own 510(k) summary have not been extracted or verified by us. | No verified retailer link | |
| Comparative analyses of three point-of-care urine drug test devices (J Appl Lab Med, 2022) The Journal of Applied Laboratory Medicine |
Professional point-of-care devices in ambulatory clinics (independent study) | Urine | Pooled across drug classes | Manufacturer-stated cutoffs (not listed in the abstract) | A for the three evaluated devices only | Article page (full text for subscribers) | Three professional point-of-care devices, 106 residual clinical specimens; we use only the abstract's pooled figures. Not evidence about any home kit. | No verified retailer link | |
| Laboratory and clinical evaluation of on-site urine drug testing (Scand J Clin Lab Invest, 2014) Scandinavian Journal of Clinical and Laboratory Investigation |
On-site testing in a laboratory and a dependency clinic (independent study) | Urine | Pooled across drug classes | Not stated in the abstract | Unverified (product not named in the abstract) | PubMed abstract, PMID 25046332 | The accessible abstract does not name the product or give sample counts, so its figures cannot be tied to any device; on-site clinical testing, not home use. | No verified retailer link |
"Analytes" uses short codes: AMP amphetamine, BAR barbiturates, BUP buprenorphine, BZO benzodiazepines, COC cocaine, EDDP methadone metabolite, MDMA, MET methamphetamine, MOP morphine (300 ng/mL), MTD methadone, OPI opiates (2,000 ng/mL), OXY oxycodone, PCP phencyclidine, PPX propoxyphene, TCA tricyclic antidepressants, THC marijuana metabolite. Each record page shows the label used in its source.
Evidence tiers
A tier describes one claim from one source, not a product. A record can hold claims at different tiers. Full definitions and the reviewer checklist are on the methodology page.
| Tier | What it means |
|---|---|
| A | Independently published head-to-head comparative study of the identical product, analyte, cutoff and matrix, with a documented reference method and limitations. Never extended to other products. |
| B | FDA review or decision summary, or published validated laboratory data, for the identical device or variant. We say when the underlying tests were run by the sponsor or manufacturer. |
| C | Manufacturer package insert or supplier study with complete methodology, not independently verified. |
| D | Product specification sheet or retailer marketing claim only. No accuracy number is shown on this basis. |
| E | Consumer purchase review: experience only, not a performance grade. |
| Unverified | Missing exact device match, insufficient design or sample documentation, or unclear result interpretation. |
Guide pages
Read the evidence the right way
Compare records
Side by side only when analyte, cutoff, sample type and study design all match. Otherwise: insufficient comparable evidence.
What accuracy figures mean
Sensitivity, specificity, percent agreement, cutoffs, near-cutoff results, cross-reactivity and detection windows.
Independent research
Peer-reviewed studies of professional point-of-care devices, with their design and limits.
How to choose a test kit
Panels, cutoffs, specimen types, labelling, FDA clearance and CLIA waiver, and questions to ask before buying.
Review policy
Four evidence labels kept apart, verified-purchase rules and affiliate disclosure. None awarded yet.
Methodology and corrections
Evidence tiers, reviewer checklist, link checks and the corrections log.
Six kinds of testing
The main categories, explained
These are categories, not products. We describe what is generally true of each kind of test as far as official sources support it. A specific product's own instructions always take priority.
Single-substance urine strips
One test for one drug or drug class, named on the label. Useful when an agreement covers one specific substance. It tells you nothing about anything else.
Multi-panel urine strips or cards
Several tests on one device. Each "panel" is one drug or drug class. The number of panels tells you how many, not which ones, so read the list on the label.
All-in-one urine cups
A collection cup with test strips built into it, so the sample is collected and screened in one container. The same panel and cutoff questions apply as for strips and cards.
Oral-fluid (saliva) screens
Use saliva instead of urine. FDA's examples of oral-fluid tests are listed under laboratory and workplace settings, so check whether a specific product's labelling says it is intended for home use.
Home kits with optional mail-in lab confirmation
A home screen plus a way to send the sample to a laboratory. FDA describes some home kits as including a shipping container and a prepaid mailer for the laboratory.
Professional laboratory testing
Included here for education only. A laboratory analyses the sample; FDA describes laboratories doing a preliminary analysis and, if that is positive, a more complete analysis.
Side by side
Comparing the categories
A general comparison of testing categories. It does not describe any particular brand or model.
| Category | Specimen | What it typically screens | How results are read | Typical uses | Main limitations | Lab confirmation included? |
|---|---|---|---|---|---|---|
| Single-substance urine strip | Urine | One drug or drug class named on the label | Read by eye within the time the instructions set; qualitative (whether a drug may be present, not how much) | Agreements that focus on one substance | Says nothing about substances it does not test for; a positive is preliminary | No. A preliminary positive should be sent for laboratory testing |
| Multi-panel urine strip or card | Urine | Several drugs or drug classes, one per panel, as listed on the label | Read by eye within the set time; each panel read separately; qualitative | Agreements covering more than one substance | The panel count is not a list of substances; anything not listed is not tested; a positive is preliminary | No, unless the kit says otherwise |
| All-in-one urine cup | Urine | Several drugs or drug classes, as listed on the label | Read by eye within the set time; qualitative | Collecting and screening in one container | Same as multi-panel tests; check the listed substances and cutoffs | No, unless the kit says otherwise |
| Oral-fluid (saliva) screen | Oral fluid (saliva) | The drugs or drug classes listed on the label | As set out in the product's instructions | FDA's examples are in laboratory and workplace settings | Check whether the labelling says home use; results depend on timing | Check the product's instructions |
| Home kit with mail-in lab confirmation | Usually urine (as stated by the kit) | The home screen covers the listed substances; the laboratory follows up on the sample | Home screen read by eye; laboratory reports separately | When a preliminary positive needs a laboratory result | A laboratory result is not immediate; laboratory fees may or may not be included, so check | Yes, as an option. Check what the price includes |
| Professional laboratory testing | Depends on the laboratory (for example urine, oral fluid or hair) | Set by the laboratory or the person ordering the test | Reported by the laboratory | Confirming a preliminary result; situations that need a formal result | Arranged and paid for separately; results are not immediate, because the sample goes to a laboratory | It is the laboratory test |
Based on general descriptions from the U.S. Food and Drug Administration (sources below). Individual products differ. Always follow the instructions that come with the exact test you use.
Cost clarity
What testing costs
We do not list prices, because we have not verified any. When you compare costs yourself, these points make the comparison fair:
- Compare the cost per test, not the pack price. Multi-packs and single tests are not directly comparable.
- Compare kits that screen for the same substances at the same cutoffs. A cheaper kit that tests for fewer substances is a different product.
- Check whether laboratory confirmation is included or extra. FDA notes that for home collection kits, the purchase price usually covers the laboratory analysis; for other kits, confirmation may be a separate cost.
- Check the expiry date against how often your schedule is likely to select a test day, so you are not paying for tests that will expire unused.
For organizations
Procurement & testing resources for organizations
For program administrators, procurement staff and reviewers who need to document why a screening device was selected.
- Record the exact device name, manufacturer, format and 510(k) number, and keep a copy of the FDA database record and decision summary with the date it was retrieved.
- Confirm the intended use on the record. A prescription or point-of-care clearance, such as K091612, does not cover over-the-counter use, and an over-the-counter clearance does not by itself establish suitability for a formal program.
- Require documentary evidence from the supplier before treating a white-label or resold product as the cleared device.
- Match analytes and cutoffs to the written policy, and compare devices only on identical analyte, cutoff, sample type and study design (see the comparison rule).
- Define the confirmation pathway in policy before any screening starts. Formal workplace programs may require a certified laboratory, chain of custody and Medical Review Officer review; see confirmation testing.
- Have the program reviewed by qualified counsel. Selecting a device from this page does not make any program compliant with law or regulation.
The evidence catalog on this site is public product information only. It contains no participant, test-result or account data.
Sources
- U.S. Food and Drug Administration, "Drugs of Abuse Home Use Test" (content current as of 27 September 2018; read 21 October 2026). Supports: home tests are qualitative urine screens; results are read visually within a set number of minutes; a preliminary positive should go to a laboratory; no test of this type is 100% accurate; some kits include a shipping container and prepaid mailer.
- U.S. Food and Drug Administration, "Drugs of Abuse Tests" (read 21 October 2026). Supports: example oral-fluid tests are listed under laboratory and workplace settings; urine examples include over-the-counter use.
- U.S. Food and Drug Administration, "Drugs of Abuse (Collection Kit)" (content current as of 27 September 2018; read 21 October 2026). Supports: collection kits send a sample to a laboratory; the price usually covers the analysis; laboratories do a preliminary analysis and, if positive, a more complete one.
- FDA 510(k) decision summaries and database records for K091588, K091612 and K221871, and the abstracts of PubMed 34597363 and 25046332: cited figure by figure on each record page.
This guide is general education, not medical, legal or purchasing advice.
Page last updated